Meningococcal (Men B)

Meningococcal Serogroup B  (aka Trumenba or Bexsero)

Recommended between 16 to 18 years of age

10+ years(if local outbreak; absent or damaged spleen; complement deficiency)

16-18 years  2nd dose 6 months after 1st dose